EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Biological Assessment of Novel Aminobenzidazole Agonists Targeting the Stimulator of Interferon Genes (STING) Receptor Signaling Pathway for Oncology Immunotherapy

Yiqing Fan, Zeqi Zeng, Jiaxian Mo, Zike Wang, Hongyu Jiang, Juanjuan Liu, Hai Qian iD, Wei Shi

ChemMedChem · 2025

DOI: 10.1002/cmdc.202400695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Yiqing Fan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China. Hauptthemen laut MEDLINE: Benzimidazoles, Drug Design, Neoplasms, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The activation of the STING‐mediated signaling pathway leads to the secretion of type I interferon (IFN) and the activation of tumor‐specific T cells. STING, a pattern recognition receptor located on the endoplasmic reticulum membrane of immune cells, binds with endogenous cyclic dinucleotides. STING undergoes phosphorylation, triggering the STING‐TBK1‐IRF3 pathway and NF‐κB pathway, resulting in the release of IFN‐β and other pro‐inflammatory cytokines, ultimately enhancing the activation of tumor‐specific T cells. This mechanism serves to complement the limitations of immune checkpoint inhibitors and enhances the efficiency of the immune response. This study selected benzimidazole compounds GSK and SR‐717 , which exhibit promising potential as patented medicines, as our lead compounds. Aiming to address the challenges associated with the short half‐life of benzimidazole compounds and the limited molecular activity of SR‐717 , we designed and synthesized a series of STING agonists ( compounds 6~29 ). The compound 17 showed excellent agonistic activity on hSTING protein in vitro . The cytotoxicity tests of all the synthesized compounds were performed in vitro . Performed in vivo pharmacokinetic studies on the most promising compounds and conducted molecular docking analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesDrug DesignNeoplasmsMembrane ProteinsAntineoplastic Agents, ImmunologicalAnimalsHumansMiceCell Line, TumorDrug Screening Assays, AntitumorImmunotherapyInterferonsMolecular Docking SimulationMolecular StructureSignal TransductionSTING Protein

Stichwörter der Autor:innen

AgonistsAntitumor agentsBiological activityDrug designSTINGTumor immunotherapy

Substanzen

BenzimidazolesInterferonsMembrane ProteinsAntineoplastic Agents, ImmunologicalSTING1 protein, humanSTING Protein

Autor:innen und Institutionen

  • Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China.
  • Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China.

ORCID-Profile: Hai Qian

Förderung

  • National Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Fan, Y., Zeng, Z., Mo, J., Wang, Z., Jiang, H., Liu, J., Qian, H., & Shi, W. (2025). Design, Synthesis, and Biological Assessment of Novel Aminobenzidazole Agonists Targeting the Stimulator of Interferon Genes (STING) Receptor Signaling Pathway for Oncology Immunotherapy. ChemMedChem. https://doi.org/10.1002/cmdc.202400695

Vancouver

Fan Y, Zeng Z, Mo J, Wang Z, Jiang H, Liu J, et al. Design, Synthesis, and Biological Assessment of Novel Aminobenzidazole Agonists Targeting the Stimulator of Interferon Genes (STING) Receptor Signaling Pathway for Oncology Immunotherapy. ChemMedChem. 2025. doi:10.1002/cmdc.202400695

BibTeX
@article{Fan2025,
  author = {Fan, Yiqing and Zeng, Zeqi and Mo, Jiaxian and Wang, Zike and Jiang, Hongyu and Liu, Juanjuan and Qian, Hai and Shi, Wei},
  title = {Design, Synthesis, and Biological Assessment of Novel Aminobenzidazole Agonists Targeting the Stimulator of Interferon Genes (STING) Receptor Signaling Pathway for Oncology Immunotherapy},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202400695}
}
Kostenlos starten →